ReviewRomanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
Wild-type transthyretin cardiac amyloidosis: a case of multisystemic involvement and review of literature.
Review in Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCardiac amyloidosis (CA) represents a progressively evolving infiltrative pathology, defined by the myocardial accumulation of amyloid fibrils. The condition predominantly originates from transthyretin-derived (ATTR) or immunoglobulin light chain-related (AL) amyloidosis. ATTR cardiomyopathy (ATTR-CM), particularly the wild-type (wt) form (wtATTR-CM), is becoming more widely acknowledged as a contributor to cardiac dysfunction in the elderly population. However, diagnosing ATTR-CM remains challenging due to its clinical similarity to other cardiac conditions and a history of frequent misdiagnoses. Recent advancements in nuclear imaging using bone-avid radiotracers have greatly improved the ability to diagnose ATTR-CM non-invasively. CASE PRESENTATION: This case involves an 86-year-old male with documented peripheral joint disease, supraspinatus tendon rupture affecting both limbs, referred for exertional dyspnea. Echocardiography indicated left ventricular hypertrophy, diastolic dysfunction, reduced global longitudinal strain, accompanied by severe mitral regurgitation (MR) secondary to prolapse of the posterior mitral leaflet. Cardiac magnetic resonance (CMR) imaging revealed concentric hypertrophy, elevated T1 mapping, and increased extracellular volume, highly suggestive of amyloid deposition. Bone scintigraphy confirmed the diagnosis of ATTR-CM with a Perugini score of 3. A biopsy of the abdominal fat pad revealed amyloid deposits.
conclusionsSuch presentations of ATTR-CM emphasize its systemic nature and the need for early recognition and treatment. An important aspect of this case is the uncommon association between CA and posterior mitral valve prolapse, which leads to significant MR.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.